Gracell Biotechnologies Inc.

CIK 1826492 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gracell Biotechnologies Inc..

Recent SEC filings

FiledFormAccession number
Mar 4, 202415-12G0001104659-24-030345
Feb 27, 2024EFFECT9999999995-24-000558
Feb 27, 2024EFFECT9999999995-24-000552
Feb 26, 2024S-8 POS0001104659-24-027602
Feb 26, 2024S-8 POS0001104659-24-027596
Feb 26, 2024POS AM0001104659-24-027597
Feb 26, 2024POS AM0001104659-24-027601
Feb 22, 202425-NSE0001354457-24-000103
Feb 22, 20246-K0001104659-24-026350
Feb 20, 20246-K0001104659-24-025242
Feb 14, 2024SC 13G0001214659-24-002596
Feb 14, 2024SC 13G/A0001104659-24-022966
Feb 14, 2024SC 13G/A0001104659-24-023999
Feb 13, 2024SC 13G/A0001213900-24-013387
Feb 13, 2024SC 13G/A0001213900-24-013458
Jan 30, 20246-K0001104659-24-007929
Jan 17, 20246-K0001104659-24-004493
Jan 8, 20246-K0001104659-24-002226
Jan 2, 20246-K0001104659-23-130577
Dec 26, 20236-K0001104659-23-129003
Dec 22, 20236-K0001104659-23-128419
Dec 18, 20236-K0001104659-23-126860
Nov 21, 20231440001973379-23-000208
Nov 14, 20236-K0001104659-23-117505
Oct 19, 2023SC 13G/A0000950142-23-002635